V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 240002444 | 240005113 | 1.7 | 88 | null | null | 2017-11-09 | GEMTUZUMAB OZOGAMICIN | 02 | null | ANAGRELIDE | 100239144 |
| 240002446 | 240005115 | 1.78 | 75.35 | Curative (C) | 2020-08-18 | 2020-10-19 | AML Relapsed High Dose Cytarabine | 2 | null | DOCETAXEL + GEMCITABINE | 101836967 |
| 240002448 | 240005117 | 1.67 | 67 | Palliative (P) | 2018-09-01 | 2018-09-10 | Venetoclax | 02 | N | CLADRIBINE | 100616707 |
| 240002449 | 240005118 | 1.88 | 18.3 | 03 | 2015-10-16 | 2015-10-24 | Arsenic trioxide + Tretinoin | 02 | N | CISPLATIN + GEMCITABINE + RITUXIMAB | 100365555 |
| 240002450 | 240005119 | 1.77 | 102 | 03 | 2019-08-02 | 2019-08-06 | null | 02 | N | CYTARABINE + ETOPOSIDE + IFOSFAMIDE + RITUXIMAB | 101381460 |
| 240002451 | 240005120 | 1.82 | 99.4 | null | null | 2017-07-22 | DA 3+8 | N | null | CML IMATINIB | 101411499 |
| 240002452 | 240005121 | 1.67 | 84.5 | Curative (C) | 2016-08-24 | 2016-09-05 | Alemtuz+Fludara+Melphalan RIC MUD | 02 | null | ANAGRELIDE | 100463616 |
| 240002453 | 240005122 | 1.76 | 22.1 | null | 2016-10-23 | 2016-10-28 | null | 02 | null | NOT MATCHED | 100564439 |
| 240002455 | 240005124 | 1.63 | 70.6 | null | null | 2016-07-13 | FLAIR trial | null | null | BUSULFAN | 100291586 |
| 240002458 | 240005126 | 0 | 77.7 | null | 2018-02-01 | 2018-02-01 | Alemtuz+Fludara+Melphalan RIC MUD | 02 | null | ANTI-THYMOCYTE GLOBULIN + CYCLOPHOSPHAMIDE + FLUDARABINE | 101461048 |
| 240002459 | 240005127 | 1.77 | 56.8 | Curative (C) | null | 2016-03-06 | null | null | null | TRIPLE INTRATHECAL | 100291554 |
| 240002460 | 240005128 | 1.59 | 59.2 | Curative (C) | 2019-02-19 | 2019-02-19 | Alemtuzumab + Cyclophos TBI Allo | 02 | N | IMATINIB | 101381163 |
| 240002462 | 240005130 | 1.68 | 21.2 | null | null | 2019-12-05 | RUXOLITINIB | null | null | CYTARABINE + FLUDARABINE + IDARUBICIN | 100078568 |
| 240002463 | 240005131 | 1.62 | 70 | Palliative (P) | 2016-10-30 | 2016-10-30 | AML Interim Guidelines FLAG-Ida | 02 | N | AML MYECHILD 01 FLA-IDARUBICIN | 100142426 |
| 240002464 | 240005132 | 1.74 | 75 | Curative (C) | 2019-01-02 | 2019-01-03 | null | 02 | null | CISPLATIN + GEMCITABINE | 100983348 |
| 240002465 | 240005133 | 1.75 | 70.2 | Curative (C) | 2019-11-11 | 2019-11-14 | CNS LGG2004 03 vinc + carbo | 02 | N | CISPLATIN + CYTARABINE + ETOPOSIDE | 100420854 |
| 240002468 | 240005136 | 1.83 | null | null | 2017-06-26 | 2017-07-10 | null | 02 | null | AML MYECHILD 01 IT CYT | 101132559 |
| 240002469 | 240005137 | 1.61 | 78.8 | null | null | 2018-03-22 | Cytarabine High Dose | N | N | CYTARABINE + FLUDARABINE + IDARUBICIN | 101284049 |
| 240002473 | 240005140 | null | 69.9 | Curative (C) | 2021-02-18 | 2021-02-18 | Methotrexate intrathecal | 02 | N | CYCLOPHOSPHAMIDE | 101350298 |
| 240002475 | 240005142 | 1.69 | 92.6 | Curative (C) | 2018-09-17 | 2018-09-20 | IBRUTINIB | 02 | N | AML MYECHILD 01 HD ARAC | 101163175 |
| 240002476 | 240005143 | 1.7 | 57.6 | Disease modification (D) | 2018-10-25 | 2018-11-09 | BEAM | 01 | null | FCR | 101575743 |
| 240002477 | 240005144 | 1.65 | 76.3 | null | 2016-11-24 | 2016-11-30 | null | 02 | N | CISPLATIN + GEMCITABINE | 100865088 |
| 240002478 | 240005145 | 1.69 | 122 | Not known (9) | 2017-05-31 | 2017-06-04 | DA 3+8 | 02 | null | CLADRIBINE + RITUXIMAB | 100059700 |
| 240002479 | 240005146 | 0 | 0 | Curative (C) | 2016-07-30 | 2016-08-17 | IBRUTINIB | null | null | ALL UKALL2011 MAINTENANCE | 100574708 |
| 240002480 | 240005147 | 0 | 0 | null | 2019-10-15 | 2019-10-17 | null | null | null | VENETOCLAX | 100017183 |
| 240002483 | 240005149 | 1.6 | 100.4 | null | 2018-09-29 | 2018-09-30 | Methotrexate intrathecal | 02 | null | BUSULFAN | 100299973 |
| 240002484 | 240005150 | 1.5 | 79.4 | null | 2018-11-13 | 2018-12-30 | null | 01 | null | CYTARABINE HIGH DOSE | 100246627 |
| 240002486 | 240005151 | 1.81 | 71.4 | 03 | 2018-03-12 | 2018-04-30 | CYTARABINE + FLUDARABINE | Y | N | CISPLATIN + GEMCITABINE + RITUXIMAB | 101706950 |
| 240002487 | 240005152 | 1.81 | 28.4 | null | 2017-10-20 | 2017-10-27 | CNS Low Grade Glioma Vinblastine | 02 | N | CARMUSTINE + THIOTEPA | 100475949 |
| 240002488 | 240005153 | 1.5 | 84 | Curative (C) | null | 2019-08-13 | DA-EPOCH-R | null | N | IMATINIB | 101212606 |
| 240002490 | 240005155 | 0 | 96 | Curative (C) | 2016-10-17 | 2016-10-23 | Venetoclax | N | null | ANAGRELIDE | 101094558 |
| 240002492 | 240005157 | 1.65 | 89 | Curative (C) | 2016-03-04 | 2016-03-08 | ALL ALLR3: S/IR Cons: Wk 7-8 | 02 | N | CYCLOPHOSPHAMIDE + RITUXIMAB | 101353212 |
| 240002494 | 240005159 | 1.67 | 66.9 | 03 | null | 2018-05-02 | null | N | N | FLUOROURACIL + OXALIPLATIN | 101692205 |
| 240002495 | 240005160 | 1.66 | 84.5 | 03 | 2017-10-26 | 2017-10-26 | FLAG + Idarubicin | 02 | null | DABRAFENIB | 100103582 |
| 240002496 | 240005161 | 1.68 | 94 | Curative (C) | null | 2017-09-16 | BENDAMUSTINE + CYTARABINE + RITUXIMAB | 02 | N | TRIPLE INTRATHECAL | 101701485 |
| 240002497 | 240005162 | 1.79 | 77.6 | Curative (C) | 2021-07-03 | 2021-07-06 | PEG INTERFERON | 02 | N | CML IMATINIB | 101306815 |
| 240002499 | 240005163 | 1.62 | 71.2 | Curative (C) | 2019-08-31 | 2019-08-31 | null | 02 | null | FLUDARABINE + MELPHALAN | 100537484 |
| 240002500 | 240005164 | 1.03 | 66.9 | null | 2017-03-26 | 2017-03-27 | R CODOX M | 02 | Y | ALEMTUZUMAB + FLUDARABINE + MELPHALAN | 101569519 |
| 240002501 | 240005165 | 1.51 | 64 | Palliative (P) | 2020-07-31 | 2021-06-01 | null | 02 | null | CYCLOPHOSPHAMIDE + VINCRISTINE | 100078158 |
| 240002503 | 240005166 | 1.54 | 91.6 | Palliative (P) | 2017-04-01 | 2017-04-14 | TRANSPLANT BEAM | 02 | N | CYTARABINE + DAUNORUBICIN | 101580316 |
| 240002504 | 240005167 | 1.72 | 84.3 | Palliative (P) | 2019-09-27 | 2019-09-27 | null | 99 | N | TRANSPLANT ALEMTUZUMAB + FLUDARABINE + MELPHALAN | 101763300 |
| 240002506 | 240005168 | 1.61 | 23.6 | Curative (C) | 2016-10-01 | 2016-10-08 | R IVAC | null | N | CNS HGG TEMOZOLOMIDE MAINTENANCE | 101199436 |
| 240002508 | 240005170 | 1.66 | 83.6 | 03 | null | null | IMATINIB | null | null | CISPLATIN + GEMCITABINE | 101439681 |
| 240002510 | 240005172 | 1.65 | 100.5 | Disease modification (D) | 2019-03-30 | 2019-04-24 | IBRUTINIB | 02 | null | ENZALUTAMIDE | 101776866 |
| 240002512 | 240005174 | 1.67 | 9.95 | Curative (C) | 2018-12-25 | 2019-01-04 | null | N | N | AML MYECHILD 01 FLA-IDARUBICIN | 100149522 |
| 240002514 | 240005175 | 0 | 74.35 | null | 2016-11-18 | 2016-11-24 | CHLORAMBUCIL + OBINUTUZUMAB | 02 | null | AML MYECHILD 01 TRIPLE IT | 100020626 |
| 240002516 | 240005177 | 1.53 | 17.15 | Curative (C) | 2019-01-22 | 2019-01-22 | ALL UKALL2011 Std BFM Cons B | 02 | null | CNS MEDBL HR CISPLATIN/VINCRISTINE/CYCLOPHOSPHAMIDE | 101152607 |
| 240002517 | 240005178 | 1.57 | 74.4 | Curative (C) | null | 2019-09-24 | Capecitabine | null | N | CYCLOPHOSPHAMIDE + DOCETAXEL + EPIRUBICIN | 101137899 |
| 240002518 | 240005179 | 1.77 | 56 | Curative (C) | 2018-05-24 | 2018-05-31 | BUSULFAN | 02 | null | IXAZOMIB + LENALIDOMIDE | 101274491 |
| 240002519 | 240005180 | 1.85 | 93 | null | 2017-11-22 | 2018-02-19 | GEMTUZUMAB OZOGAMICIN | 01 | null | ALEMTUZUMAB + FLUDARABINE + MELPHALAN | 101262604 |